Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology

Despite important advances in diagnosis and treatment, heart failure (HF) remains a syndrome with substantial morbidity and dismal prognosis. Although implementation and optimization of existing technologies and drugs may lead to better management of HF, new or alternative strategies are desirable. In this regard, basic science is expected to give fundamental inputs, by expanding the knowledge of the pathways underlying HF development and progression, identifying approaches that may improve HF detection and prognostic stratification, and finding novel treatments. Here, we discuss recent basic science insights that encompass major areas of translational research in HF and have high potential clinical impact.

• Publication year

  2020

• Venue

  International Journal of Molecular Sciences

• Publication date

  2020-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/ijms21041192PMID 32054029PMCID 7072832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular nanomedicine: the route ahead.

  2019cited by this paper
• Current Landscape of Heart Failure Gene Therapy

  2019cited by this paper
• Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.

  2019cited by this paper
• Nitrosative stress drives heart failure with preserved ejection fraction

  2019cited by this paper
• The novel butyrate derivative phenylalanine‐butyramide protects from doxorubicin‐induced cardiotoxicity

  2019influential reference
• The gut microbiome and heart failure: A better gut for a better heart

  2019cited by this paper
• Nanoparticle Based Treatment for Cardiovascular Diseases.

  2019cited by this paper
• Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.

  2019cited by this paper
• 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.

  2019influential reference
• Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

  2019cited by this paper
• Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy

  2018cited by this paper
• Diet, the Gut Microbiome and Heart Failure

  2018cited by this paper
• Novel Beneficial Cardiovascular Effects of Natural Activators of Autophagy.

  2018cited by this paper
• Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health

  2018influential reference
• Autophagy and proinflammatory cytokines: Interactions and clinical implications.

  2018cited by this paper
• Heart failure with preserved ejection fraction: from mechanisms to therapies

  2018influential reference
• A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases

  2018cited by this paper
• Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

  2018influential reference
• New Insights Into the Role of mTOR Signaling in the Cardiovascular System.

  2018cited by this paper
• The Role of Autophagy in the Heart.

  2018influential reference
• Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth

  2018cited by this paper
• Cardiac effects of SGLT2 inhibitors: the sodium hypothesis

  2018cited by this paper
• Inhalation of peptide-loaded nanoparticles improves heart failure

  2018cited by this paper
• Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury

  2018cited by this paper
• Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage

  2018cited by this paper
• Dietary metabolism, the gut microbiome, and heart failure

  2018cited by this paper
• Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis

  2017cited by this paper
• Inflammation – Cause or Consequence of Heart Failure or Both?

  2017cited by this paper
• Cell signaling abnormalities in cardiomyopathy caused by lamin A/C gene mutations.

  2017cited by this paper
• Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis

  2017cited by this paper
• Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.

  2017cited by this paper
• Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes

  2017cited by this paper
• Progress in Nanomedicine: Approved and Investigational Nanodrugs.

  2017cited by this paper
• Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy

  2017influential reference
• Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions

  2017cited by this paper
• Applications of nanoparticle systems in drug delivery technology

  2017cited by this paper
• Functional Role of Nox4 in Autophagy.

  2017cited by this paper
• The Metabolodiuretic Promise of Sodium-Dependent Glucose Cotransporter 2 Inhibition: The Search for the Sweet Spot in Heart Failure.

  2017cited by this paper
• Dilated Cardiomyopathy: Genetic Determinants and Mechanisms

  2017cited by this paper
• Medicated Nanoparticle for Gene Delivery

  2017cited by this paper
• Inflammation, metaflammation and immunometabolic disorders

  2017cited by this paper
• Progress in Nanomedicine: Approved and Investigational Nanodrugs.

  2017cited by this paper
• Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.

  2016cited by this paper
• Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

  2016cited by this paper
• Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy.

  2016cited by this paper
• 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2016cited by this paper
• Pathogenic Gut Flora in Patients With Chronic Heart Failure.

  2016cited by this paper
• Therapeutic targeting of autophagy in cardiovascular disease.

  2016cited by this paper
• Cardioprotection and lifespan extension by the natural polyamine spermidine

  2016cited by this paper
• Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies

  2016cited by this paper
• Aging and Autophagy in the Heart.

  2016cited by this paper
• Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap

  2016cited by this paper
• Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs.

  2016cited by this paper
• Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload–Induced Mitochondrial Dysfunction and Heart Failure

  2016cited by this paper
• Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification

  2016cited by this paper
• Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy.

  2016cited by this paper
• 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs.

  2015influential reference
• Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart.

  2015cited by this paper
• [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].

  2015cited by this paper
• Dilated Cardiomyopathy Overview

  2015cited by this paper
• Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity

  2015influential reference
• Modulation of inflammation by autophagy: Consequences for human disease

  2015cited by this paper
• Innate immunity and the failing heart: the cytokine hypothesis revisited.

  2015cited by this paper
• The war against heart failure: the Lancet lecture.

  2015influential reference
• Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.

  2014influential reference
• A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.

  2014cited by this paper
• The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions

  2014cited by this paper
• Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study).

  2014cited by this paper
• Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation*

  2014cited by this paper
• Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery.

  2013cited by this paper
• Enhanced autophagy ameliorates cardiac proteinopathy.

  2013cited by this paper
• Overexpression of Atg5 in mice activates autophagy and extends lifespan

  2013cited by this paper
• Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era.

  2013cited by this paper
• Autophagy in human health and disease.

  2013influential reference
• Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy

  2013influential reference
• Activation of NADPH Oxidase 4 in the Endoplasmic Reticulum Promotes Cardiomyocyte Autophagy and Survival During Energy Stress Through the Protein Kinase RNA-Activated-Like Endoplasmic Reticulum Kinase/Eukaryotic Initiation Factor 2&agr;/Activating Transcription Factor 4 Pathway

  2013cited by this paper
• Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart

  2013cited by this paper
• Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy.

  2013cited by this paper
• Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival.

  2012cited by this paper
• Truncations of titin causing dilated cardiomyopathy.

  2012cited by this paper
• A histone deacetylase inhibitory prodrug - butyroyloxymethyl diethyl phosphate - protects the heart and cardiomyocytes against ischemia injury.

  2012cited by this paper
• Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure.

  2012cited by this paper
• Mitochondrial DNA That Escapes from Autophagy Causes Inflammation and Heart Failure

  2012cited by this paper
• Inhibitory effect of dietary lipids on chaperone-mediated autophagy

  2012cited by this paper
• Preparation, Characterization, Pharmacokinetics and Tissue Distribution of Solid Lipid Nanoparticles Loaded with Tetrandrine

  2011cited by this paper
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

  2011cited by this paper
• Caloric Restriction Mimetic 2-Deoxyglucose Antagonizes Doxorubicin-induced Cardiomyocyte Death by Multiple Mechanisms*

  2011cited by this paper
• Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging

  2011cited by this paper
• TFEB Links Autophagy to Lysosomal Biogenesis

  2011cited by this paper
• Autophagy: Renovation of Cells and Tissues

  2011influential reference
• Atg7 Induces Basal Autophagy and Rescues Autophagic Deficiency in CryABR120G Cardiomyocytes

  2011cited by this paper
• Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy.

  2010cited by this paper
• Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

  2010cited by this paper
• Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.

  2010cited by this paper
• Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?

  2009cited by this paper
• Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.

  2009cited by this paper
• Lamin A/C deficiency as a cause of familial dilated cardiomyopathy

  2009cited by this paper
• Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death*

  2009cited by this paper
• Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.

  2008cited by this paper
• Nanovehicular intracellular delivery systems.

  2008cited by this paper

• Dual SGLT1/2 inhibition with sotagliflozin: a pharmaceutical breakthrough in heart failure management and cardiometabolic risk reduction

  2026cites this paper
• Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies.

  2024cites this paper
• Exercise training attenuates cardiac dysfunction induced by excessive sympathetic activation through an AMPK-KLF4-FMO2 axis.

  2024cites this paper
• Forkhead box O6 (FoxO6) promotes cardiac pathological remodeling and dysfunction by activating Kif15–TGF‐β1 under aggravated afterload

  2023cites this paper
• Crosstalk between Mfn2-mediated mitochondria associated membranes disorder and autophagy induced by molybdenum and cadmium in sheep heart.

  2023cites this paper
• The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats

  2023cites this paper
• Features of Prediction of Heart Failure in Patients with Peripheral Atherosclerosis During a Three-Year Prospective Follow-Up

  2022cites this paper
• The Neuroimmune Role of Intestinal Microbiota in the Pathogenesis of Cardiovascular Disease

  2021cites this paper
• From Genetic Mutations to Molecular Basis of Heart Failure Treatment: An Overview of the Mechanism and Implication of the Novel Modulators for Cardiac Myosin

  2021cites this paper
• Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity

  2021cites this paper